Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 45

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 45
---
 25th percentile of the market. In response, the compensation committee decided to increase the salaries of the named executive officers (except for Mr. Taich, who had not yet joined the company) in March 2024 to ensure competitiveness, reflect their skills, experience and performance and support their continued success in

#### 10X GENOMICS, INC.452025 PROXY STATEMENT
driving key strategic priorities. As a result, the salaries of all named executive officers, except the Chief Executive Officer, were adjusted to align with the market 50th percentile. The Chief Executive Officer’s base salary remains below the peer 25th percentile (as does his total target cash compensation).

• Annual Incentive Plan: In 2024, we maintained our Annual Incentive Plan (AIP) for employees, including named executive officers. The AIP’s funding formula focused on financial and operational metrics such as revenue, adjusted free cash flow and strategic business objectives. We maintained the target incentive opportunity for all named executive officers at the same level as 2023.

• Equity Incentives: Named executive officers are eligible for equity awards as part of our compensation program, which aligns pay with performance and provides retention incentives. In 2024, the compensation committee granted RSUs and PSUs, modifying the PSU program based on shareholder feedback by incorporating long-term relative TSR and CAGR metrics. These changes further strengthen the link between executive and stockholder interests.

#### Compensation Elements

#### Base Salary
Base salaries for our named executive officers provide a fixed level of compensation for their services and day-to-day performance. Salary levels are reviewed annually or upon significant changes in role or responsibilities, and for all named executive officers except the Chief Executive Officer, in consultation with the Chief Executive Officer. Salary adjustments are not formulaic but are based on factors such as (a) the skills and responsibilities required, (b) company and individual performance, (c) competitive market conditions and (d) relevant experience.

Since our IPO, we have adjusted the mix of compensation to align more closely with public company practices, balancing dilution for stockholders while emphasizing both short-term results and long-term stock performance. In April 2024, we increased base salaries for named executive officers to bring them closer to the market 50th percentile, with the exception of the CEO, whose salary remains below the 25th percentile of peers.

The annualized base salaries of our named executive officers as of December 31, 2024 compared to December 31,